Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index
In a prospective study evaluating risk factors for indinavir-related renal colic in 555 HIV-infected patients receiving highly active antiretroviral therapy, followed-up fir 24 months, 23.6% developed one or more renal colic episodes, and 50 patients stopped indinavir. No correlation was observed be...
Gespeichert in:
| Veröffentlicht in: | AIDS (London) 2002-10, Vol.16 (15), p.2089-2093 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2093 |
|---|---|
| container_issue | 15 |
| container_start_page | 2089 |
| container_title | AIDS (London) |
| container_volume | 16 |
| creator | MERAVIGLIA, Paola ANGELI, Elena DEL SORBO, Francesca ROMBOLA, Giuseppe VIGANO, Paolo ORLANDO, Giovanna CORDIER, Laura FAGGION, Ivano CARGNEL, Antonietta |
| description | In a prospective study evaluating risk factors for indinavir-related renal colic in 555 HIV-infected patients receiving highly active antiretroviral therapy, followed-up fir 24 months, 23.6% developed one or more renal colic episodes, and 50 patients stopped indinavir. No correlation was observed between renal colic onset and sex, age, CD4 cell count, history, and hepatitis B or C virus co-infection, but baseline anthropometric values were significantly related to the onset of renal colic. |
| doi_str_mv | 10.1097/00002030-200210180-00019 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00002030_200210180_00019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12370513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c286t-7e1e120a0e4cf80cf1d05ccebcb3b908d002647cba3f2df8ac31f3275abe04903</originalsourceid><addsrcrecordid>eNpFkNFLwzAQxoMobk7_BcmLj3GXpF1T32SoGwwEUV9Lmlwg2rUl6Yb-92ZuuoPj4O77PrgfIZTDLYeymEIqARKYSJMDV8DShpcnZMyzQrI8L_gpGYOYlayUBYzIRYwfSZKDUudkxEVa5lyOSXjx8ZM6bYYuROq6QH1rfau3PrCAjR7Q0oCtbqjpGm_SlS6W77TXg8d2iHe0D2i9GfwW6VY3G6SdO0ZQ20Wc1p39pmsd4-6AX5fkzOkm4tVhTsjb48PrfMFWz0_L-f2KGaFmAyuQIxegATPjFBjHLeTGYG1qWZegbHp9lhWm1tIJ65Q2kjspilzXCFkJckLUPteELsaAruqDX-vwXXGodhirP4zVP8bqF2OyXu-t_aZeoz0aD9yS4OYg0NHoxgXdGh-PugyEnKX-AXsifCc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>MERAVIGLIA, Paola ; ANGELI, Elena ; DEL SORBO, Francesca ; ROMBOLA, Giuseppe ; VIGANO, Paolo ; ORLANDO, Giovanna ; CORDIER, Laura ; FAGGION, Ivano ; CARGNEL, Antonietta</creator><creatorcontrib>MERAVIGLIA, Paola ; ANGELI, Elena ; DEL SORBO, Francesca ; ROMBOLA, Giuseppe ; VIGANO, Paolo ; ORLANDO, Giovanna ; CORDIER, Laura ; FAGGION, Ivano ; CARGNEL, Antonietta</creatorcontrib><description>In a prospective study evaluating risk factors for indinavir-related renal colic in 555 HIV-infected patients receiving highly active antiretroviral therapy, followed-up fir 24 months, 23.6% developed one or more renal colic episodes, and 50 patients stopped indinavir. No correlation was observed between renal colic onset and sex, age, CD4 cell count, history, and hepatitis B or C virus co-infection, but baseline anthropometric values were significantly related to the onset of renal colic.</description><identifier>ISSN: 0269-9370</identifier><identifier>EISSN: 1473-5571</identifier><identifier>DOI: 10.1097/00002030-200210180-00019</identifier><identifier>PMID: 12370513</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams & Wilkins</publisher><subject>Adult ; Biological and medical sciences ; Body Mass Index ; Colic - chemically induced ; Dose-Response Relationship, Drug ; Drug toxicity and drugs side effects treatment ; Female ; HIV Infections - drug therapy ; HIV Protease Inhibitors - administration & dosage ; HIV Protease Inhibitors - adverse effects ; Humans ; Indinavir - administration & dosage ; Indinavir - adverse effects ; Kidney Calculi ; Kidney Diseases - chemically induced ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Pharmacology. Drug treatments ; Predictive Value of Tests ; Prospective Studies ; Risk Factors ; Toxicity: urogenital system ; Urinary lithiasis</subject><ispartof>AIDS (London), 2002-10, Vol.16 (15), p.2089-2093</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c286t-7e1e120a0e4cf80cf1d05ccebcb3b908d002647cba3f2df8ac31f3275abe04903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14023602$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12370513$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MERAVIGLIA, Paola</creatorcontrib><creatorcontrib>ANGELI, Elena</creatorcontrib><creatorcontrib>DEL SORBO, Francesca</creatorcontrib><creatorcontrib>ROMBOLA, Giuseppe</creatorcontrib><creatorcontrib>VIGANO, Paolo</creatorcontrib><creatorcontrib>ORLANDO, Giovanna</creatorcontrib><creatorcontrib>CORDIER, Laura</creatorcontrib><creatorcontrib>FAGGION, Ivano</creatorcontrib><creatorcontrib>CARGNEL, Antonietta</creatorcontrib><title>Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index</title><title>AIDS (London)</title><addtitle>AIDS</addtitle><description>In a prospective study evaluating risk factors for indinavir-related renal colic in 555 HIV-infected patients receiving highly active antiretroviral therapy, followed-up fir 24 months, 23.6% developed one or more renal colic episodes, and 50 patients stopped indinavir. No correlation was observed between renal colic onset and sex, age, CD4 cell count, history, and hepatitis B or C virus co-infection, but baseline anthropometric values were significantly related to the onset of renal colic.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Body Mass Index</subject><subject>Colic - chemically induced</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Protease Inhibitors - administration & dosage</subject><subject>HIV Protease Inhibitors - adverse effects</subject><subject>Humans</subject><subject>Indinavir - administration & dosage</subject><subject>Indinavir - adverse effects</subject><subject>Kidney Calculi</subject><subject>Kidney Diseases - chemically induced</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Pharmacology. Drug treatments</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Toxicity: urogenital system</subject><subject>Urinary lithiasis</subject><issn>0269-9370</issn><issn>1473-5571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkNFLwzAQxoMobk7_BcmLj3GXpF1T32SoGwwEUV9Lmlwg2rUl6Yb-92ZuuoPj4O77PrgfIZTDLYeymEIqARKYSJMDV8DShpcnZMyzQrI8L_gpGYOYlayUBYzIRYwfSZKDUudkxEVa5lyOSXjx8ZM6bYYuROq6QH1rfau3PrCAjR7Q0oCtbqjpGm_SlS6W77TXg8d2iHe0D2i9GfwW6VY3G6SdO0ZQ20Wc1p39pmsd4-6AX5fkzOkm4tVhTsjb48PrfMFWz0_L-f2KGaFmAyuQIxegATPjFBjHLeTGYG1qWZegbHp9lhWm1tIJ65Q2kjspilzXCFkJckLUPteELsaAruqDX-vwXXGodhirP4zVP8bqF2OyXu-t_aZeoz0aD9yS4OYg0NHoxgXdGh-PugyEnKX-AXsifCc</recordid><startdate>20021018</startdate><enddate>20021018</enddate><creator>MERAVIGLIA, Paola</creator><creator>ANGELI, Elena</creator><creator>DEL SORBO, Francesca</creator><creator>ROMBOLA, Giuseppe</creator><creator>VIGANO, Paolo</creator><creator>ORLANDO, Giovanna</creator><creator>CORDIER, Laura</creator><creator>FAGGION, Ivano</creator><creator>CARGNEL, Antonietta</creator><general>Lippincott Williams & Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20021018</creationdate><title>Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index</title><author>MERAVIGLIA, Paola ; ANGELI, Elena ; DEL SORBO, Francesca ; ROMBOLA, Giuseppe ; VIGANO, Paolo ; ORLANDO, Giovanna ; CORDIER, Laura ; FAGGION, Ivano ; CARGNEL, Antonietta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c286t-7e1e120a0e4cf80cf1d05ccebcb3b908d002647cba3f2df8ac31f3275abe04903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Body Mass Index</topic><topic>Colic - chemically induced</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Protease Inhibitors - administration & dosage</topic><topic>HIV Protease Inhibitors - adverse effects</topic><topic>Humans</topic><topic>Indinavir - administration & dosage</topic><topic>Indinavir - adverse effects</topic><topic>Kidney Calculi</topic><topic>Kidney Diseases - chemically induced</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Pharmacology. Drug treatments</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Toxicity: urogenital system</topic><topic>Urinary lithiasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MERAVIGLIA, Paola</creatorcontrib><creatorcontrib>ANGELI, Elena</creatorcontrib><creatorcontrib>DEL SORBO, Francesca</creatorcontrib><creatorcontrib>ROMBOLA, Giuseppe</creatorcontrib><creatorcontrib>VIGANO, Paolo</creatorcontrib><creatorcontrib>ORLANDO, Giovanna</creatorcontrib><creatorcontrib>CORDIER, Laura</creatorcontrib><creatorcontrib>FAGGION, Ivano</creatorcontrib><creatorcontrib>CARGNEL, Antonietta</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>AIDS (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MERAVIGLIA, Paola</au><au>ANGELI, Elena</au><au>DEL SORBO, Francesca</au><au>ROMBOLA, Giuseppe</au><au>VIGANO, Paolo</au><au>ORLANDO, Giovanna</au><au>CORDIER, Laura</au><au>FAGGION, Ivano</au><au>CARGNEL, Antonietta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index</atitle><jtitle>AIDS (London)</jtitle><addtitle>AIDS</addtitle><date>2002-10-18</date><risdate>2002</risdate><volume>16</volume><issue>15</issue><spage>2089</spage><epage>2093</epage><pages>2089-2093</pages><issn>0269-9370</issn><eissn>1473-5571</eissn><abstract>In a prospective study evaluating risk factors for indinavir-related renal colic in 555 HIV-infected patients receiving highly active antiretroviral therapy, followed-up fir 24 months, 23.6% developed one or more renal colic episodes, and 50 patients stopped indinavir. No correlation was observed between renal colic onset and sex, age, CD4 cell count, history, and hepatitis B or C virus co-infection, but baseline anthropometric values were significantly related to the onset of renal colic.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams & Wilkins</pub><pmid>12370513</pmid><doi>10.1097/00002030-200210180-00019</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-9370 |
| ispartof | AIDS (London), 2002-10, Vol.16 (15), p.2089-2093 |
| issn | 0269-9370 1473-5571 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_00002030_200210180_00019 |
| source | MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Biological and medical sciences Body Mass Index Colic - chemically induced Dose-Response Relationship, Drug Drug toxicity and drugs side effects treatment Female HIV Infections - drug therapy HIV Protease Inhibitors - administration & dosage HIV Protease Inhibitors - adverse effects Humans Indinavir - administration & dosage Indinavir - adverse effects Kidney Calculi Kidney Diseases - chemically induced Male Medical sciences Nephrology. Urinary tract diseases Pharmacology. Drug treatments Predictive Value of Tests Prospective Studies Risk Factors Toxicity: urogenital system Urinary lithiasis |
| title | Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T12%3A02%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20factors%20for%20indinavir-related%20renal%20colic%20in%20HIV%20patients:%20predictive%20value%20of%20indinavir%20dose/body%20mass%20index&rft.jtitle=AIDS%20(London)&rft.au=MERAVIGLIA,%20Paola&rft.date=2002-10-18&rft.volume=16&rft.issue=15&rft.spage=2089&rft.epage=2093&rft.pages=2089-2093&rft.issn=0269-9370&rft.eissn=1473-5571&rft_id=info:doi/10.1097/00002030-200210180-00019&rft_dat=%3Cpubmed_cross%3E12370513%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/12370513&rfr_iscdi=true |